ADVFN US – Market Content Editor
-
Gold Breaks $4,000 Barrier to Record High as Global Uncertainty Spurs Safe-Haven Rush
Gold prices surged to fresh record highs in Asian trading on Wednesday, surpassing the $4,000 per ounce milestone for the first time ever as investors sought refuge amid deepening political and economic instability across major economies. The rally was supported by growing expectations that the U.S. Federal Reserve will deliver additional interest rate cuts this…
-
Stellantis Announces New Leadership for Europe and Global Manufacturing in Executive Restructure
Stellantis (NYSE:STLA) CEO Antonio Filosa has announced another round of leadership changes, appointing new heads for the company’s European operations and global manufacturing, just days after naming a new chief financial officer. Emanuele Cappellano, who currently oversees Stellantis’ South American division, will assume the role of Head of Enlarged Europe and European Brands, succeeding Jean-Philippe…
-
U.S. Stocks Give Back Ground, S&P 500 Snaps 7-Day Winning Streak
Following the upward move seen over the course of the previous session, stocks gave back some ground during trading on Tuesday. The major averages all moved to the downside, with the Nasdaq and the S&P 500 pulling back off Monday’s record closing highs. The major averages finished the day off their worst levels but still…
-
Terra Innovatum, GSR III Acquisition Corp. Approve $130 Million Merger
October 7, 2025 — Terra Innovatum Srl, a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (NASDAQ:GSRT) announced that shareholders have approved their proposed business combination, paving the way for Terra Innovatum to become a publicly traded company. The deal, valued at $130 million in total proceeds, received approval at GSR III’s Extraordinary…
-
Johnson & Johnson hit with $966 million verdict in baby powder cancer lawsuit
A Los Angeles jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $966 million to the family of a woman who died from mesothelioma, ruling that the company’s baby powder was responsible for her illness. The decision, delivered late Monday, marks the latest major verdict in a long-running wave of lawsuits accusing the healthcare giant…
-
Gold futures top $4,000 for the first time as global turmoil boosts safe-haven demand
Gold futures climbed to a historic milestone on Tuesday, briefly breaking through the $4,000-per-ounce barrier for the first time, as investors sought refuge from mounting political uncertainty and economic instability across major global markets. Expectations of further U.S. interest rate cuts also added momentum to the rally. By 10:02 ET (14:02 GMT), gold futures were…
-
Urgently shares skyrocket after announcing partnership with Sony Honda Mobility
Urgently Inc. (NASDAQ:ULY) shares soared 55.8% on Tuesday following news that the roadside assistance technology company has entered into a strategic partnership with Sony Honda Mobility of America (SHMA) to support the launch of the AFEELA electric vehicle brand. Under the agreement, AFEELA drivers will have access to nationwide roadside and mobility assistance across all…
-
Dell shares surge after company boosts revenue growth outlook to 7–9%
Dell Technologies (NYSE:DELL) stock climbed 6% on Tuesday morning after the technology giant raised its long-term annual revenue growth target to 7–9%, up from the previous 3–4% range, signaling growing confidence in its ability to capitalize on accelerating demand for artificial intelligence (AI) infrastructure. The company also nearly doubled its annual non-GAAP earnings per share…
-
PayPal shares rally after launching Ads Manager platform for small businesses
PayPal Holdings (NASDAQ:PYPL) climbed 5% on Tuesday after the payments giant introduced PayPal Ads Manager, a new advertising platform designed to help small businesses generate additional revenue by monetizing their online traffic. Set to debut in early 2026 in the United States, followed by rollouts in the UK and Germany, the Ads Manager aims to…
-
Humacyte shares plunge after announcing $60 million registered direct offering
Humacyte Inc. (NASDAQ:HUMA) shares fell 17% on Tuesday after the biotechnology company revealed plans for a $60 million registered direct offering, sparking investor concerns over share dilution. The commercial-stage biotech firm, which develops universally implantable bioengineered human tissues, said it had entered into a securities purchase agreement with a group of institutional investors to sell…